Literature DB >> 31874189

Kallikrein-kinin system and oxidative stress in cisplatin-induced ovarian toxicity.

Laura Silveira Ayres1, Markus Berger2, Isabel Cirne Lima de Oliveira Durli3, Cristiana Palma Kuhl4, Paula Barros Terraciano5, Tuane Nerissa Alves Garcez6, Bruna Gomes Dos Santos7, Jorge Almeida Guimarães8, Eduardo Pandolfi Passos9, Elizabeth Obino Cirne-Lima10.   

Abstract

Kallikrein-kinin system (KKS) is involved in vascular reactivity and inflammatory response to cytotoxic drugs. Since cisplatin is a widely used chemotherapy and its cytotoxic mechanism can trigger inflammation and oxidative damage, in this work we evaluated the role of KKS in an animal model of cisplatin-induced ovarian toxicity. Biomarkers of ovarian stem cells, activity of KKS, inflammation and oxidative damage were measured in ovarian tissue of C57BL/6 female mice treated with vehicle or cisplatin (2.5 mg/kg). Cisplatin group presented greater number of atretic follicles, and lower numbers of antral and total viable follicles. Ki67, DDX4 and OCT-4 markers were similar between groups. Cisplatin triggered plasma and ovarian tissue kallikrein generation; and increased expression of bradykinin receptors B1 and B2. Neutrophil and macrophage infiltration markers increased. Superoxide anion generation also increased, while reduced glutathione levels decreased. These results suggest that KKS is activated and contributes to ovarian injury during cisplatin treatment.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bradykinin; Chemotherapy; Cisplatin; Inflammatory cytokines; Ovarian toxicity

Year:  2019        PMID: 31874189     DOI: 10.1016/j.reprotox.2019.12.002

Source DB:  PubMed          Journal:  Reprod Toxicol        ISSN: 0890-6238            Impact factor:   3.143


  4 in total

1.  Senotherapy Protects against Cisplatin-Induced Ovarian Injury by Removing Senescent Cells and Alleviating DNA Damage.

Authors:  Dingfu Du; Xianan Tang; Yufeng Li; Yueyue Gao; Runhua Chen; Qian Chen; Jingyi Wen; Tong Wu; Yan Zhang; Huan Lu; Jinjin Zhang; Shixuan Wang
Journal:  Oxid Med Cell Longev       Date:  2022-06-03       Impact factor: 7.310

Review 2.  Bradykinin-target therapies in SARS-CoV-2 infection: current evidence and perspectives.

Authors:  Manuele Figueiredo da Silva; João Xavier de Araújo-Júnior; Edeildo Ferreira da Silva-Júnior; Luana Heimfarth; Paulo Ricardo Martins-Filho; Jullyana de Souza Siqueira Quintans; Lucindo José Quintans-Júnior
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2022-01-28       Impact factor: 3.000

3.  Curcumin Prevents Epithelial-to Mesenchymal Transition-Mediated Ovarian Cancer Progression through NRF2/ETBR/ET-1 Axis and Preserves Mitochondria Biogenesis in Kidney after Cisplatin Administration.

Authors:  Agian Jeffilano Barinda; Wawaimuli Arozal; Ni Made Dwi Sandhiutami; Melva Louisa; Nur Arfian; Normalina Sandora; Muhammad Yusuf
Journal:  Adv Pharm Bull       Date:  2020-09-19

4.  Amburana cearensis leaf extract protects against cisplatin-induced ovarian damage through regulation of p-PTEN and p-Akt proteins in mice.

Authors:  Bruna B Gouveia; Ricássio S Barberino; Vanúzia G Menezes; Alane P O Monte; Regina Lucia S Silva; Raimundo C Palheta; Larissa A Rolim; Emanuella C V Pereira; Raimundo G Oliveira; Jackson Roberto G S Almeida; Maria Helena T Matos
Journal:  Iran J Basic Med Sci       Date:  2022-06       Impact factor: 2.532

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.